Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp > Whats the consensus on the two presentations this month?

<< Previous

Bullboard Posts

Next >>

Comment by krikoon Jun 02, 2021 6:29pm

240 Views

Post# 33315836

RE:Whats the consensus on the two presentations this month?

I have heard from reliable source that they will present more info on Patients 1 and 2 (at ATC) and that this will include recent results (i.e. since Dec 2020). Sernova will need to issue a press release after the presentation to match the disclosure at ATC. Depending on what is disclosed, it could mean that Monday morning might get a little wild.

<< Previous

Bullboard Posts

Next >>

High-growth stock Happy Belly opens first Rosie's Burgers in Alberta